Cargando…
Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action
The use of pharmaceuticals for colon cancer treatment has been increasingly personalized, in part due to the development of new molecular tools. In this review, we discuss the old and new colon cancer chemotherapeutics, and the parameters that have been shown to be predictive of efficacy and safety...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817731/ https://www.ncbi.nlm.nih.gov/pubmed/24276379 http://dx.doi.org/10.3390/ph6080988 |